The T cell oncogene Tal2 is necessary for normal development of the mouse brain

被引:29
作者
Bucher, K
Sofroniew, MV
Pannell, R
Impey, H
Smith, AJH
Torres, EM
Dunnett, SB
Jin, Y
Baer, R
Rabbitts, TH
机构
[1] MRC, Mol Biol Lab, Cambridge CB2 2QH, England
[2] MRC, Ctr Brain Repair, Cambridge CB2 2PY, England
[3] Univ Texas, SW Med Sch, Dallas, TX 75235 USA
关键词
homologous recombination; chromosomal translocations; leukemia; transcription; helix-loop-helix; tectum; brain; hydrocephalus; cancer;
D O I
10.1006/dbio.2000.9920
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Transcription factors are commonly involved in leukemia by activation through chromosomal translocations and normally function in cell type(s) that differ from that of the tumor. TAl2 is a member of a basic helix-loop-helix gene family specifically involved in T cell leukemogenesis. Null mutations of Tal2 have: been made in mice to determine its function during development. Tal2 null mutant mice show no obvious defects of hematopoiesis. During embryogenesis, Tal2 expression is restricted to the developing midbrain, dorsal diencephalon, and rostroventral diencepharic/telencephalic boundary, partly along presumptive developing fiber tracts. The null mutant mice are viable at birth but growth become progressively retarded and they do not survive to reproductive age. Tal2-deficient mice show a distinct dysgenesis of the midbrain tectum. Due to loss of superficial gray and optical layers, the superior colliculus is reduced in size and the inferior colliculus is abnormally rounded and protruding. Death is most likely due to progressive hydrocephalus which appears to be caused by obstruction of the foramen of Monro (the connection between the ventricles of the forebrain). Thus, in addition to its oncogenicity when ectopically expressed, Ta12 normally plays a pivotal role in brain development and without this gene, mice cannot survive to maturity.
引用
收藏
页码:533 / 544
页数:12
相关论文
共 41 条
[1]   TRANSGENES AS PROBES FOR ACTIVE CHROMOSOMAL DOMAINS IN MOUSE DEVELOPMENT [J].
ALLEN, ND ;
CRAN, DG ;
BARTON, SC ;
HETTLE, S ;
REIK, W ;
SURANI, MA .
NATURE, 1988, 333 (6176) :852-855
[2]  
BAER R, 1993, SEMIN CANCER BIOL, V4, P341
[3]   DOES ACTIVATION OF THE TAL1 GENE OCCUR IN A MAJORITY OF PATIENTS WITH T-CELL ACUTE LYMPHOBLASTIC-LEUKEMIA - A PEDIATRIC-ONCOLOGY-GROUP STUDY [J].
BASH, RO ;
HALL, S ;
TIMMONS, CF ;
CRIST, WM ;
AMYLON, M ;
SMITH, RG ;
BAER, R .
BLOOD, 1995, 86 (02) :666-676
[4]   The roles of intrinsic and extrinsic cues and bHLH genes in the determination of retinal cell fates [J].
Cepko, CL .
CURRENT OPINION IN NEUROBIOLOGY, 1999, 9 (01) :37-46
[5]   COMPLEMENTARY GRADIENTS IN EXPRESSION AND BINDING OF ELF-1 AND MEK4 IN DEVELOPMENT OF THE TOPOGRAPHIC RETINOTECTAL PROJECTION MAP [J].
CHENG, HJ ;
NAKAMOTO, M ;
BERGEMANN, AD ;
FLANAGAN, JG .
CELL, 1995, 82 (03) :371-381
[6]   ONCOGENIC CONVERSION OF TRANSCRIPTION FACTORS BY CHROMOSOMAL TRANSLOCATIONS [J].
CLEARY, ML .
CELL, 1991, 66 (04) :619-622
[7]   TOUCHDOWN PCR TO CIRCUMVENT SPURIOUS PRIMING DURING GENE AMPLIFICATION [J].
DON, RH ;
COX, PT ;
WAINWRIGHT, BJ ;
BAKER, K ;
MATTICK, JS .
NUCLEIC ACIDS RESEARCH, 1991, 19 (14) :4008-4008
[8]   IN-VITRO GUIDANCE OF RETINAL GANGLION-CELL AXONS BY RAGS, A 25 KDA TECTAL PROTEIN RELATED TO LIGANDS FOR EPH RECEPTOR TYROSINE KINASES [J].
DRESCHER, U ;
KREMOSER, C ;
HANDWERKER, C ;
LOSCHINGER, J ;
NODA, M ;
BONHOEFFER, F .
CELL, 1995, 82 (03) :359-370
[9]   FORMATION OF IN-VIVO COMPLEXES BETWEEN THE TAL1 AND E2A POLYPEPTIDES OF LEUKEMIC T-CELLS [J].
HSU, HL ;
WADMAN, I ;
BAER, R .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (08) :3181-3185
[10]   ENHANCER-BINDING ACTIVITY OF THE TAL-1 ONCOPROTEIN IN ASSOCIATION WITH THE E47/E12 HELIX-LOOP-HELIX PROTEINS [J].
HSU, HL ;
CHENG, JT ;
CHEN, Q ;
BAER, R .
MOLECULAR AND CELLULAR BIOLOGY, 1991, 11 (06) :3037-3042